This inventor holds 1 USPTO granted patent. Top assignee: Yungjin Pharm Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Dong-Joon Oh
Introduction
Dong-Joon Oh is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that enhance the efficacy of medications. His work is characterized by a focus on creating formulations that provide both rapid and long-acting effects.
Latest Patents
Dong-Joon Oh holds a patent for a pharmaceutical composition that simultaneously exhibits rapid-acting and long-acting properties. This innovative composition includes a sustained-release part coated with a water-insoluble polymer, which contains a first active pharmaceutical ingredient and a release control base. Additionally, it features an immediate release part that comprises a second active pharmaceutical ingredient. This unique formulation allows for independent release properties of both parts, making it a versatile option for various therapeutic applications.
Career Highlights
Dong-Joon Oh is associated with Yungjin Pharm Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the effectiveness of pharmaceutical products, contributing to improved patient outcomes.
Collaborations
Throughout his career, Dong-Joon Oh has collaborated with esteemed colleagues, including Dae-hee Shin and Byoung-Ki Kim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Dong-Joon Oh's contributions to pharmaceutical innovation exemplify the impact of dedicated research and development in the medical field. His patented work on pharmaceutical compositions showcases his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile